# Gain Therapeutics, Inc.: filings

GANX · Nasdaq · CIK 1819411 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ganx.md) · [Financials](/companies/ganx/financials.md) · [Filings](/companies/ganx/filings.md) · [Insiders](/companies/ganx/insiders.md)

## Reports and events: 99 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 67, 4 65, 10-Q 17, 3 14, UPLOAD 9, 424B5 8, CORRESP 8, 10-K 5, DEF 14A 5, S-8 5, ARS 4, DEFA14A 4, DRSLTR 3, EFFECT 3, 4/A 2, DRS/A 2, S-1 2, S-1/A 2, S-3 2, S-3/A 2, 10-K/A 1, 3/A 1, 424B3 1, 424B4 1, 8-A12B 1, CERT 1, D 1, DRS 1, FWP 1, PRE 14A 1, SC 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 17:00 ET | [8-K](/filings/0001104659-26-119673.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-119673 |
| 2026-10-01 | 09:16 ET | [8-K](/filings/0001104659-26-112624.md) | 8.01 Other events | 0001104659-26-112624 |
| 2026-09-28 | 16:30 ET | [8-K](/filings/0001104659-26-111391.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-111391 |
| 2026-08-11 | 16:07 ET | [10-Q](/filings/0001104659-26-094048.md) | Quarterly report, period 2026-06-30 | 0001104659-26-094048 |
| 2026-08-11 | 16:05 ET | [8-K](/filings/0001104659-26-094041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-094041 |
| 2026-07-16 | 07:53 ET | [8-K](/filings/0001104659-26-084086.md) | 8.01 Other events | 0001104659-26-084086 |
| 2026-06-29 | 16:21 ET | [8-K](/filings/0001104659-26-078848.md) | 8.01 Other events | 0001104659-26-078848 |
| 2026-06-25 | 17:00 ET | [8-K](/filings/0001104659-26-077820.md) | 5.07 Shareholder vote results | 0001104659-26-077820 |
| 2026-05-26 | 09:26 ET | [8-K](/filings/0001104659-26-066062.md) | 8.01 Other events | 0001104659-26-066062 |
| 2026-05-11 | 16:08 ET | [10-Q](/filings/0001104659-26-058649.md) | Quarterly report, period 2026-03-31 | 0001104659-26-058649 |
| 2026-05-11 | 16:05 ET | [8-K](/filings/0001104659-26-058636.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-058636 |
| 2026-04-28 | 16:45 ET | [DEF 14A](/filings/0001104659-26-050431.md) | Proxy statement, period 2026-06-24 | 0001104659-26-050431 |
| 2026-03-26 | 16:07 ET | [10-K](/filings/0001104659-26-035188.md) | Annual report, period 2025-12-31 | 0001104659-26-035188 |
| 2026-03-26 | 16:05 ET | [8-K](/filings/0001104659-26-035174.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-035174 |
| 2026-03-18 | 08:51 ET | [8-K](/filings/0001104659-26-029968.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-029968 |
| 2026-02-03 | 16:25 ET | [8-K](/filings/0001104659-26-009747.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-009747 |
| 2025-12-18 | 09:00 ET | [8-K](/filings/0001104659-25-122353.md) | 8.01 Other events | 0001104659-25-122353 |
| 2025-11-28 | 16:03 ET | [8-K](/filings/0001104659-25-116947.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-116947 |
| 2025-11-12 | 16:09 ET | [10-Q](/filings/0001104659-25-110347.md) | Quarterly report, period 2025-09-30 | 0001104659-25-110347 |
| 2025-11-12 | 16:06 ET | [8-K](/filings/0001104659-25-110343.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-110343 |
| 2025-10-14 | 16:56 ET | [8-K](/filings/0001104659-25-099343.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-099343 |
| 2025-10-09 | 16:30 ET | [8-K](/filings/0001104659-25-098376.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-098376 |
| 2025-10-06 | 17:01 ET | [8-K](/filings/0001104659-25-097153.md) | 8.01 Other events | 0001104659-25-097153 |
| 2025-08-12 | 16:05 ET | [10-Q](/filings/0001558370-25-011220.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011220 |
| 2025-08-12 | 16:03 ET | [8-K](/filings/0001558370-25-011218.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-011218 |
| 2025-07-17 | 07:30 ET | [8-K](/filings/0001104659-25-068530.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-068530 |
| 2025-06-30 | 16:30 ET | [8-K](/filings/0001104659-25-064145.md) | 8.01 Other events | 0001104659-25-064145 |
| 2025-06-24 | 17:09 ET | [8-K](/filings/0001104659-25-062162.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-062162 |
| 2025-05-14 | 16:08 ET | [10-Q](/filings/0001558370-25-007747.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007747 |
| 2025-05-14 | 16:06 ET | [8-K](/filings/0001558370-25-007744.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007744 |
| 2025-04-29 | 16:05 ET | [DEF 14A](/filings/0001558370-25-005829.md) | Proxy statement, period 2025-06-24 | 0001558370-25-005829 |
| 2025-04-10 | 16:49 ET | [8-K](/filings/0001104659-25-033797.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-033797 |
| 2025-03-27 | 16:21 ET | [10-K](/filings/0001558370-25-003823.md) | Annual report, period 2024-12-31 | 0001558370-25-003823 |
| 2025-03-27 | 16:02 ET | [8-K](/filings/0001558370-25-003807.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-003807 |
| 2025-02-06 | 16:50 ET | [8-K](/filings/0001104659-25-010148.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-010148 |
| 2025-01-15 | 17:00 ET | [8-K](/filings/0001104659-25-003801.md) | 3.01 Delisting notice | 0001104659-25-003801 |
| 2025-01-07 | 17:00 ET | [8-K](/filings/0001104659-25-001711.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-001711 |
| 2024-12-23 | 08:30 ET | [8-K](/filings/0001104659-24-131084.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-131084 |
| 2024-11-14 | 16:07 ET | [10-Q](/filings/0001558370-24-015709.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015709 |
| 2024-11-14 | 16:02 ET | [8-K](/filings/0001558370-24-015705.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-015705 |
| 2024-10-21 | 17:22 ET | [8-K](/filings/0001104659-24-110287.md) | 8.01 Other events | 0001104659-24-110287 |
| 2024-10-08 | 16:30 ET | [8-K](/filings/0001104659-24-107052.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-107052 |
| 2024-09-06 | 17:00 ET | [8-K](/filings/0001104659-24-097781.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-097781 |
| 2024-08-08 | 16:05 ET | [10-Q](/filings/0001558370-24-011589.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011589 |
| 2024-08-08 | 16:03 ET | [8-K](/filings/0001558370-24-011585.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-011585 |
| 2024-07-12 | 17:24 ET | [8-K](/filings/0001104659-24-079601.md) | 3.01 Delisting notice | 0001104659-24-079601 |
| 2024-07-09 | 17:18 ET | [8-K](/filings/0001104659-24-078600.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-078600 |
| 2024-06-28 | 17:00 ET | [8-K](/filings/0001104659-24-076341.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-076341 |
| 2024-06-25 | 17:20 ET | [8-K](/filings/0001104659-24-074822.md) | 5.07 Shareholder vote results | 0001104659-24-074822 |
| 2024-06-14 | 16:40 ET | [8-K](/filings/0001104659-24-071801.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-071801 |

Page 1 of 2. [Older](/companies/ganx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 17:20 ET. No prices; not investment advice.